Everest Medicines is a Chinese biopharmaceutical company based in New York City, New York.
History
On September 13, 2021, Providence Therapeutics announced that it had entered into two separate contracts with Everest Medicines to license rights to their mRNA COVID-19 vaccine candidates to markets in China, Southeast Asia and Pakistan, and to establish a broader global partnership around the mRNA platform.[1]
External links
Forester, N., Wong, N., Robinson, D., & Lococo, E. (2021, September 13). Providence Therapeutics Enters into Comprehensive Agreements with Everest Medicines to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Emerging Markets in Asia. Providence Therapeutics. http://archive.today/2022.07.12-143338/https://providencetherapeutics.com/press-details/providence-therapeutics-enters-into-comprehensive-agreements-with-everest-medicines-to-advance-mrna-vaccines-and-therapies-including-covid-19-vaccines-in-emerging-markets-in-asia.html ↩︎
